Abstract

Progranulin (PGRN) has been reported to bind tumor necrosis factor (TNF) receptor and to inhibit TNFα signaling. We evaluated the effect of augmentation of TNFα signaling by PGRN deficiency on the progression of kidney injury. Eight-week-old PGRN knockout (KO) and wild-type (WT) mice were fed a standard diet or high-fat diet (HFD) for 12 weeks. Albuminuria, markers of tubular damage, and renal mRNA levels of inflammatory cytokines were higher in HFD-fed KO (KO-HFD) mice than in HFD-fed WT (WT-HFD) mice. Body weight, vacuolization in proximal tubules, and systemic and adipose tissue inflammatory markers were lower in the KO-HFD mice than in the WT-HFD mice. The renal megalin expression was lower in the KO mice than in the WT mice regardless of the diet type. The megalin expression was also reduced in mouse proximal tubule epithelial cells stimulated with TNFα and in those with PGRN knockdown by small interfering RNA in vitro. PGRN deficiency was associated with both exacerbated renal inflammation and decreased systemic inflammation, including that in the adipose tissue of mice with HFD-induced obesity. Improved tubular vacuolization in the KO-HFD mice might partially be explained by the decreased expression of megalin in proximal tubules.

Highlights

  • Progranulin (PGRN) has been reported to bind tumor necrosis factor (TNF) receptor and to inhibit TNFα signaling

  • There were no significant differences in body weight, food intake, albumin/creatinine ratio (ACR), and the levels of urinary kidney injury molecule-1 (KIM-1), serum TNFα, serum TNFR1, serum TNFR2, and urinary 8-Oxo-2′-deoxyguanosine (8-OHdG) between the standard diet (SD)-fed PGRN-KO (KO-SD) group and the SD-fed WT (WT-SD) group

  • We demonstrated that PGRN deficiency was associated with exacerbated local renal inflammation in mice with high-fat diet (HFD)-induced obesity

Read more

Summary

Introduction

Progranulin (PGRN) has been reported to bind tumor necrosis factor (TNF) receptor and to inhibit TNFα signaling. We have previously shown that circulating PGRN concentrations are significantly increased in patients with type 2 diabetes and renal functional d­ ecline[8]. These findings raise the possibility that PGRN may exert beneficial or harmful effects depending on the affected organ or pathological condition. Several studies have reported that TNFα is associated with the development/progression of kidney diseases through the activation of TNF/TNFR ­pathway[19]. This study aimed to determine whether PGRN plays a beneficial or detrimental role in two different organs, kidneys and the adipose tissue, using PGRN-deficient mice with HFD-induced chronic inflammation

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call